In this episode of Conversations in Healthcare, Mike Ward, Global Head of Thought Leadership at DRG, part of Clarivate, speaks with Dr. Leen Kawas, president and CEO of Athira Pharma. Dr. Kawas shares the company’s innovative approach to treating Alzheimer’s disease by developing small molecules to restore neuronal health and stop neurodegeneration. They also discuss Athira’s recent IPO following a successful series B funding round, all during the pandemic.  Hosted on Acast. See acast.com/privacy for more information.